Diclofenac increases the accumulation of kynurenate following tryptophan pretreatment in the rat: A possible factor contributing to its antihyperalgesic effect

Inflammopharmacology

Volumn 11, Issue 3, 2003, Pages 277-292

  Edwards, Stephen R ^a   Mather, Laurence E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anti hyperalgesia; Anti nociception; Diclofenac; Kynurenate; Kynurenine; N methyl D aspartate receptors; Non steroidal antiinflammatory drugs; Tryptophan

Indexed keywords

DICLOFENAC; KYNURENIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE; TRYPTOPHAN;

AMINO ACID URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERALGESIA; KIDNEY; LIVER; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRYPTOPHAN METABOLISM;

EID: 0041821324     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856003322315622     Document Type: Article

References (27)

1. Appleton, I. (1997). Non-steroidal anti-inflammatory drugs and pain, in: The Pharmacology of Pain - Handbook of Experimental Pharmacology, Vol. 130, Dickenson, A. and Besson, J. M. (Eds), pp. 44-60. Springer-Verlag, Berlin.
2. Badawy, A. A. B. and Morgan, C. J. (1982). Tryptophan and tryptophan pyrrolase in haem regulation, Biochem. J. 206, 451-460.
3. Brown, R. R. (1994). Tryptophan metabolism: a review, in: L-Tryptophan: Current Prospects in Medicine and Drug Safety, Kochen, W. and Steinhart, H. (Eds.), pp. 17-30. De Gruyter, Berlin.
4. Carlton, S. M. and Coggeshall, R. E. (1999). Inflammation-induced changes in peripheral glutamate receptor populations, Brain Res. 820, 63-70.
5. Carpenedo, R., Pittaluga, A., Cozzi, A., et al. (2001). Presynaptic kynurenate-sensitive receptors inhibit glutamate release, Eur. J. Neurosci. 13, 2141-2147.
6. Chiarugi, A., Carpenedo, R., Molina, M. T., et al. (1995). Comparison of the neurochemical and behavioural effects resulting from the inhibition of kynurenine hydroxylase and/or kyureninase, J. Neurochem. 65, 1176-1183.
7. Connick, J. H., Heywood, G. C., Sills, G. J., et al. (1992). Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity, Gen. Pharmacol. 23, 235-239.
8. Davidson, E. M. and Carlton, S. M. (1998). Intraplantar injection of dextrorphan, ketamine, or memantine attenuates formalin-induced behaviours, Brain Res. 78, 136-142.
9. Davies, N. M. and Anderson, K. E. (1997). Clinical pharmacokinetics of diclofenac: therapeutic insights and pitfalls, Clin. Pharmacokinet. 33, 185-213.
10. Dickenson, A. H. (1990). A cure for wind up: NMDA receptor antagonists as potential analgesics, Trends Pharmacol. Sci. 11, 307-309.
11. Edwards, S. R., Mather, L. E., Lin, Y., et al. (2000). Glutamate and kynurenate in the rat central nervous system following treatments with tail ischaemia or diclofenac, J. Pharm. Pharmacol. 52, 59-66.
12. Fukui, S., Schwarcz, R., Rapoport, S. I., et al. (1991). Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism, J. Neurochem. 56, 2007-2017.
13. Grace, R. F., Edwards, S. R., Mather, L. E., et al. (2000). Central and peripheral tissue distribution of diclofenac after subcutaneous injection in the rat, Inflammopharmacology 8, 43-54.
14. Holmes, E. W. (1988). Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography, Anal. Biochem. 172, 518-525.
15. Kessler, M., Terramani, T., Lynch, G., et al. (1989). A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists, J. Neurochem. 52, 1319-1328.
16. Lou, G. L., Pinsky, C. and Sitar, D. S. (1994). Kynurenic acid distribution into brain and peripheral tissues of mice, Can. J. Physiol. Pharmacol. 72, 161-167.
17. McCormack, K. (1994). The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects, Drugs 47 (Suppl. 5), 28-45.
18. Moroni, F., Russi, P., Lombardi, G., et al. (1988). Presence of kynurenic acid in the mammalian brain, J. Neurochem. 51, 177-180.
19. Russi, P., Alesiani, M., Lombardi, G., et al. (1992). Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions, J. Neurochem. 59, 2076-2080.
20. Smith, Q. R., Momma, S., Aoagi, M., et al. (1987). Kinetics of neutral amino acid transport across the blood-brain barrier, J. Neurochem. 49, 1651-1658.
21. Stone, T. W. (1993). Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev. 45, 310-367.
22. Swartz, K. J., Matson, W. R., MacGarvey, U., et al. (1990). Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric elecrode array detection, Anal. Biochem. 185, 363-376.
23. Takeuchi, F. and Shibata, Y. (1984). Kynurenine metabolism in vitamin-B-6-deficient rat liver after tryptophan injection, Biochem. J. 220, 693-699.
24. Urenjak, J. and Obrenovitch, T. P. (2000). Neuroprotective potency of kynurenic acid against excitotoxicity, Neuroreport. 27, 1341-1344.
25. Widner, B., Werner, E. R., Schennach, H., et al. (1999). An HPLC method to determine tryptophan and kynurenine in serum simultaneously, Adv. Exp. Med. Biol. 467, 827-832.
26. Wong, E. and Kemp, J. A. (1991). Sites for antagonism on the N-methyl-D-aspartate receptor channel complex, Annu. Rev. Pharmacol. Toxicol. 31, 401-425.
27. Yeh, J. K. and Brown, R. R. (1977). Effects of vitamin B-6 deficiency and tryptophan loading on urinary excretion of tryptophan metabolites in mammals, J. Nutr. 107, 261-271.